Biopharma Daily Stock Updates - 07/08/21
$XBI $131.91 +0.43%
COVID Updates
$PSTI +1.4% Pluristem Brings ARDS Associated with COVID-19 Phase II Studies to Clinical Readout. source
Pipeline Updates
$IBIO +4.5% iBio Establishes Oncology Drug Discovery Pipeline with Three New Antibody Programs. source
$NMTR +20.4% 9 Meters Biopharma, Inc. To Present at the William Blair Biotech Focus Conference. source
$AKRO -0.2% Study Published in Nature Medicine Shows Investigational NASH Drug Reduced Liver Fat to Normal Levels and Reversed Fibrosis After 16 Weeks of Treatment. source
$SLS +8.2% Sellas Reports Promising Data from Combination Trials in Ovarian Cancer and Mesothelioma. source
$VOR +9.0% Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML). source
$TRVN 0% Trevena Announces First Patient Enrolled in OLINVYK® Phase 3 Trial in China in Partnership with Jiangsu Nhwa Pharmaceutical. source
$EVAX -9.9% Evaxion Biotech Reports Data from Phase 1/2a Trials of EVX-01 and EVX-02. source
$AZN -0.8% Tezepelumab regulatory submission accepted and granted FDA Priority Review in the US for the treatment of patients with asthma. source
Financial Updates
$BBIO -0.3% BridgeBio Pharma Announces Collaborations with Three Academic Research Institutions. source
$CYCN +1.4% Cyclerion Therapeutics and Beacon Biosignals Announce Expanded Strategic Partnership. source
Posted by FS
Comments